QA: RenovoRx Inc. in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001574094_2022_RenovoRx_Inc.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001574094')"}

Graph

Absolute values for 0001574094, RenovoRx Inc.

  xvar xval
0 AssetsCurrent 16,281,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 6,000
4 LiabilitiesCurrent 938,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 2,632,000
9 ResearchAndDevelopmentExpense 3,039,000
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome -653,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 16,287,000
1 Liabilities 938,000
2 Expenses 5,671,000
3 Revenues 0
4 StockholdersEquity 15,349,000
5 NetIncome -6,324,000
6 ComprehensiveNetIncome -6,324,000
7 BaseVar 11,774,500
8 EconomicCapitalRatio 2.33

Edgar->Model Mapping

Feature Distribution

Change over Time